Company: ICUI
Filing Date: 2025-08-07
Form Type: 10-Q
Source: 0000883984-25-000030
Chunk: 160

Company: ICU MEDICAL INC/DE
Filing Date: 2025-08-07
Form: 10-Q
Item: Item 8
Chunk 160
---
 demand for our Infusion Consumables and Oncology product lines.

Infusion Systems

    The following table summarizes our total Infusion Systems revenue (in millions, except percentages):

Three months ended June 30,Six months ended June 30,20252024$ Change% Change20252024$ Change% ChangeInfusion Systems (GAAP)$167.7 $163.7 $4.0 2.4 %$334.0 $321.0 $13.0 4.0 %Impact of foreign currency exchange rate changes(0.5)2.5 Infusion Systems on a constant currency basis (non-GAAP)$167.2 $336.5 $ Change in constant currency$3.5 $15.5 % Change in constant currency2.1 %4.8 %

Infusion Systems revenue increased for the three and six months ended June 30, 2025, as compared to the same periods in the prior year, primarily due to increased sales of LVP pump hardware and dedicated sets.

Vital Care

    The following table summarizes our total Vital Care revenue (in millions, except percentages):

Three months ended June 30,Six months ended June 30,20252024$ Change% Change20252024$ Change% ChangeVital Care (GAAP)$108.0 $171.0 $(63.0)(36.8)%$280.2 $336.3 $(56.1)(16.7)%Impact of foreign currency exchange rate changes(1.4)— Vital Care on a constant currency basis (non-GAAP)$106.6 $280.2 $ Change in constant currency$(64.4)$(56.1)% Change in constant currency(37.7)%(16.7)%

Vital Care revenue decreased for the three and six months ended June 30, 2025, as compared to the same periods in the prior year, primarily due to lower IV Solutions sales resulting from the sale of a controlling ownership interest in our IV Solutions business on May 1, 2025 (see Note 4: Assets Held For Sale and Disposal of Business to our accompanying condensed consolidated financial statements).

43

Gross Margins 

    For the three and six months ended June 30, 2025, gross margins were 37.9% and 36.3%, respectively, as compared to 34.8